[Alkan, B. M., Fidan, F., Erten, S., Aksekili, H., Alemdar, A., Eroglu, E., Ardicoglu, O., Tosun, A. (2013). Fatigue and correlation with disease-specific variables, spinal mobility measures, and health-related quality of life in ankylosing spondylitis. Mod. Rheumatol., 23 (6), 1101–1107.10.3109/s10165-012-0800-0]Search in Google Scholar
[Calin, A., Jones, S. D., Garrett, S. L., Kennedy, L. G. (1995). Bath Ankylosing Spondylitis Functional Index. Brit. J. Rheumatol.,34, 793–794.10.1093/rheumatology/34.8.7937551671]Open DOISearch in Google Scholar
[Davies, H., Brophy, S., Dennis, M., Cooksey, R., Irvine, E., Siebert, S. (2013). Patient perspectives of managing fatigue in Ankylosing Spondylitis, and views on potential interventions: A qualitative study. BMC Musculoskel. Disord.,14, 163.10.1186/1471-2474-14-163366814923659344]Search in Google Scholar
[Dernis-Labous, E., Messow, M., Dougados, M. (2003). Assessment of fatigue in the management of patients with ankylosing spondylitis. Rheumatology,42, 1523–1528.10.1093/rheumatology/keg42113130145]Open DOISearch in Google Scholar
[de Winter, J. J., van Mens, L. J., van der Heijde, D., Landewe, R., Baeten, D. L. (2016). Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: A meta-analysis. Arthritis Res. Ther.,18, 196.10.1186/s13075-016-1093-z500971427586785]Open DOISearch in Google Scholar
[Doran, M. F., Brophy, S., MacKay, K., Taylor, G., Calin, A. (2003). Predictors of long-term outcome in ankylosing spondylitis. J. Rheumatol.,30, 316–320.]Search in Google Scholar
[Durcan, L., Wilson, F., Conway, R., Cunnane, G., O’Shea, F.D. (2012). Increase body mass index in ankylosing spondylitis is associated with greater burden of symptoms and poor perceptions of the benefits of exercise. J. Rheumatol.,39 (12), 2310–2314.10.3899/jrheum.12059523070993]Search in Google Scholar
[Exarchou, S., Lindstrom, U., Askling, J., Eriksson, J. K., Forsblad-d’Elia, H., Neovius, M., Turesson, C., Kristensen, L. E., Jacobsson, L. T. H. (2015). The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: A nationwide register study. Arthritis Res. Ther.,17, 118.10.1186/s13075-015-0627-0442488625956915]Search in Google Scholar
[Garrett, S., Jenkinson, T., Kennedy, L. G., Whitelock, H., Gaisford, P., Calin, A. (1994). A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J. Rheumatol.,21, 2286–2291.]Search in Google Scholar
[Gremese, E., Bernardi, S., Bonazza, S., Nowik, M., Peluso, G., Massara, A., Tolusso, B., Messuti, L., Miceli, M., C., Zoli, A., Trotta, F., Govoni, M., Ferraccioli, G. (2014). Body weight, gender and response to TNF-a blockers in axial spondyloarthritis. Rheumatology,53, 875–881.10.1093/rheumatology/ket43324407233]Search in Google Scholar
[Heuft-Dorenbosch, L., van Tubergen, A., Spoorenberg, A., Landewe, R., Dougados, M., Mielants, H., van der Tempel, H., van der Heijde, D. (2004). The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum.,51, 154–159.10.1002/art.2023315077254]Open DOISearch in Google Scholar
[Jenkinson, T. R., Mallorie, P. A., Whitelock, H. C., Kennedy, L. G., Garrett, S. L., Calin, A. (1994). Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. J. Rheumatol.,21, 1694–1698.]Search in Google Scholar
[Kim, S. K., Choe, J. Y., Lee, S. S., Shin, K. (2017). Body mass index is related with the presence of syndesmophyte in axial spondyloarthritis: Data from the Korean College of Rheumatology BIOlogics (KOBIO) registry. Mod. Rheumatol.,13, 1–7.10.1080/14397595.2016.126563727919202]Search in Google Scholar
[Kim, T. J., Lee, S., Joo, K. B., Park, D. J., Park, Y. W., Lee, S. S., Kim, T. H. (2014). The presence of peripheral arthritis delays spinal radiographic progression in ankylosing spondylitis: Observation Study of the Korean Spondyloarthropathy Registry. Rheumatology,53, 1404–1408.10.1093/rheumatology/keu01424609061]Search in Google Scholar
[Maas, P., Arends, S., van der Veer, E., Wink, F., Efde, M., Bootsma, H., Brouwer, E., Spoorenberg, A. (2016). Obesity is common in axial spondyloarthritis and is associated with poor clinical outcome. J. Rheumatol.,43 (2), 383–387.10.3899/jrheum.15064826669924]Search in Google Scholar
[Machado, P., Landewé, R., Lie, E., Kvien, T. K., Braun, J., Baker, D., van der Heijde, D. (2011). Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores. Ann. Rheum. Dis.,70, 47–53.10.1136/ard.2010.13859421068095]Open DOISearch in Google Scholar
[Maffetone, P. B., Rivera-Dominguez, I., Laursen, P. B. (2017). Overfat and underfat: new terms and definitions long overdue. Front. Public Health,4, 279.10.3389/fpubh.2016.00279520623528097119]Search in Google Scholar
[Ottaviani, S., Allanore, Y., Tubach, F., Forien, M., Gardette, A., Pasquet, B., Palazzo, E., Meunier, M., Hayem, G., Job-Deslandre, C., Kahan, A., Meyer, O., Dieude, P. (2012). Body mass index influences the response to infliximab in ankylosing spondylits. Arthritis Res.Ther.,14, R115.10.1186/ar3841344649222584116]Open DOISearch in Google Scholar
[Rosas, J., Linares-Tello, F., Senabre-Callego, J. M., Barber-Valles, X., Santos-Soler, G., Salas-Heredia, E., Pons Bas, A., Cano Perez, C., Garcia-Carrasco, M. (2017). Obesity decreases clinical efficacy and levels of adalimumab in patients with ankylosing spondylitis. Clin. Exp. Rheumatol.,35 (1), 145–148.]Search in Google Scholar
[Rudwaleit, M., Haibel, H., Baraliakos, X., Listing, J., Märker-Hermann, E., Zeidler, H., Braun, J., Sieper, J. (2009). The early disease stage in axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum.,60, 717–727.10.1002/art.2448319248087]Open DOISearch in Google Scholar
[Sieper, J., Appel, H., Braun, J., Rudwaleit, M. (2008). Critical Appraisal of Assessment of Structural Damage in Ankylosing Spondylitis. Arthritis Rheum.,58, 649–656.10.1002/art.2326018311819]Open DOISearch in Google Scholar
[Stolwijk, C., van Onna, M., Boonen, A., van Tubergen, A. (2016). Global prevalence of spondyloarthritis: A systematic review and meta-regression analysis. Arthritis Care Res.,68 (9), 1320–1331.10.1002/acr.2283126713432]Search in Google Scholar
[van der Linden, S., Valkneburg, H. A., Cats, A. (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum.,27, 361–368.10.1002/art.17802704016231933]Open DOISearch in Google Scholar
[Vargas, R. R., van den Berg, R., van Lunteren, M., Ez-Zaitouni, Z., Bakker, P. A. C., Dagfinrud, H., Ramonda, R., Landewe, R., Molenaar, E., van Gaalen, F. A., van der Heijde, D. (2016). Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis? Data from the SPACE cohort. RMD Open,2, e000283.]Search in Google Scholar
[World Health Organization. Obesity and overweight. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed 12 February 2017).]Search in Google Scholar
[Zhang, X., Ding, W. (2016). Association of genetic variants in pentraxin 3 gene with ankylosing spondylitis. Med. Sci. Monit., 22, 2911–2916.10.12659/MSM.896562499901527538101]Search in Google Scholar